Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

358 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Memory B cells anticipate SARS-CoV-2 variants through somatic hypermutation.
Bruhn M, Obara M, Chiyyeadu A, Costa B, Salam A, Ziegler A, Waltl I, Pavlou A, Bonifacius A, Hoffmann M, Graalmann T, Pöhlmann S, Eiz-Vesper B, Schambach A, Kalinke U. Bruhn M, et al. Among authors: schambach a. J Infect. 2024 Jan;88(1):57-60. doi: 10.1016/j.jinf.2023.10.020. Epub 2023 Oct 31. J Infect. 2024. PMID: 37913848 Free article. No abstract available.
A tetravalent bispecific antibody outperforms the combination of its parental antibodies and neutralizes diverse SARS-CoV-2 variants.
Chiyyeadu A, Asgedom G, Bruhn M, Rocha C, Schlegel TU, Neumann T, Galla M, Vollmer Barbosa P, Hoffmann M, Ehrhardt K, Ha TC, Morgan M, Schoeder CT, Pöhlmann S, Kalinke U, Schambach A. Chiyyeadu A, et al. Among authors: schambach a. Clin Immunol. 2024 Mar;260:109902. doi: 10.1016/j.clim.2024.109902. Epub 2024 Jan 11. Clin Immunol. 2024. PMID: 38218210 Free article.
Editorial: Engineered immune cells in cancer immunotherapy (EICCI).
Martin F, Schambach A, Maccalli C. Martin F, et al. Among authors: schambach a. Front Immunol. 2022 Dec 20;13:1119363. doi: 10.3389/fimmu.2022.1119363. eCollection 2022. Front Immunol. 2022. PMID: 36605186 Free PMC article. No abstract available.
CRISPR-Cas12a for Highly Efficient and Marker-Free Targeted Integration in Human Pluripotent Stem Cells.
Hammad R, Alzubi J, Rhiel M, Chmielewski KO, Mosti L, Rositzka J, Heugel M, Lawrenz J, Pennucci V, Gläser B, Fischer J, Schambach A, Moritz T, Lachmann N, Cornu TI, Mussolino C, Schäfer R, Cathomen T. Hammad R, et al. Among authors: schambach a. Int J Mol Sci. 2024 Jan 12;25(2):985. doi: 10.3390/ijms25020985. Int J Mol Sci. 2024. PMID: 38256061 Free PMC article.
A new age of precision gene therapy.
Schambach A, Buchholz CJ, Torres-Ruiz R, Cichutek K, Morgan M, Trapani I, Büning H. Schambach A, et al. Lancet. 2024 Feb 10;403(10426):568-582. doi: 10.1016/S0140-6736(23)01952-9. Epub 2023 Nov 22. Lancet. 2024. PMID: 38006899 Review.
CAR-NK Cells Targeting HER1 (EGFR) Show Efficient Anti-Tumor Activity against Head and Neck Squamous Cell Carcinoma (HNSCC).
Nowak J, Bentele M, Kutle I, Zimmermann K, Lühmann JL, Steinemann D, Kloess S, Koehl U, Roßberg W, Ahmed A, Schaudien D, Neubert L, Kamp JC, Kuehnel MP, Warnecke A, Schambach A, Morgan M. Nowak J, et al. Among authors: schambach a. Cancers (Basel). 2023 Jun 13;15(12):3169. doi: 10.3390/cancers15123169. Cancers (Basel). 2023. PMID: 37370779 Free PMC article.
Tumor Organoid and Spheroid Models for Cervical Cancer.
Kutle I, Polten R, Hachenberg J, Klapdor R, Morgan M, Schambach A. Kutle I, et al. Among authors: schambach a. Cancers (Basel). 2023 Apr 27;15(9):2518. doi: 10.3390/cancers15092518. Cancers (Basel). 2023. PMID: 37173984 Free PMC article. Review.
358 results